Armstrong Wants Extra Year To Develop Inhaler Without Epinephrine
This article was originally published in The Tan Sheet
Executive Summary
Generic manufacturer Armstrong Pharmaceuticals is asking FDA to delay for a year until 2011 the agency's proposed rule that would force epinephrine-containing metered-dose inhalers off the market